Advertisement

Topics

Personal Genome Diagnostics, Inc. Company Profile

17:55 EST 15th February 2019 | BioPortfolio

Personal Genome Diagnostics (PGDx) empowers the fight against cancer by unlocking actionable information from the genome. We are committed to developing a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories worldwide. PGDx was established by researchers from Johns Hopkins University who are pioneers in cancer genome sequencing and liquid biopsy technologies. For additional information, visit PersonalGenome.com.


News Articles [1327 Associated News Articles listed on BioPortfolio]

Personal Genome Diagnostics’ pan-cancer assay being used in new clinical trial

Personal Genome Diagnostics, Inc., a leader in cancer genomics and pioneer in liquid biopsy, today reported that its non-invasive, pan-cancer plasma assay is being used in an important new clinical tr...

Personal Genome Diagnostics and PathGroup Partner to Accelerate the Availability of Comprehensive Genomic Profiling with TMB

BALTIMORE–(BUSINESS WIRE)–Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, and PathGroup, a premier provider of anatomic, clinical and molecular laboratory services, a...

Personal Genome Diagnostics Collaborates with Merck on Clinical Trial Evaluating Response to Dual Biomarker Directed Precision Oncology Combination Therapy

BALTIMORE–(BUSINESS WIRE)–Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today reported that its 500+ gene pan-cancer tumor profiling tissue assay is being used in M...

International Clinical Trial Utilizes Personal Genome Diagnostics’ Liquid Biopsy Assay to ...

Read more...

Macrogen opens office in Australia

South Korean biotech company Macrogen has opened an office in New South Wales, with an aim to service clients in Australia and New Zealand. The local office will offer individualised consultation a...

Personal Genome Diagnostics Collaborates with Merck on Global Clinical Trial Evaluating Response to Dual Biomarker Directed Precision Oncology Combination Therapy

— Study uses PGDx elioTM tissue TMB assay — Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today reported that its 500+ gene pan-cancer tumor...

PGDx machine learning approach outperforms existing mutation detection methods in study

(Pure Communications Inc.) Personal Genome Diagnostics, Inc. (PGDx), a leader in cancer genomics, today announced that its machine learning based technology, CerebroTM, outperformed existing methods t...

International Clinical Trial Utilizes Personal Genome Diagnostics’ Liquid Biopsy Assay to Enroll Patients based on POLE/POLD1 status as a Predictor of Response to Immunotherapy

— Study examines PGDx technology as an innovative, non-invasive approach with the potential to reduce need for tumor biopsies — Personal Genome Diagnostic...

PubMed Articles [1772 Associated PubMed Articles listed on BioPortfolio]

Decoding the Genomics of Abdominal Aortic Aneurysm.

A key aspect of genomic medicine is to make individualized clinical decisions from personal genomes. We developed a machine-learning framework to integrate personal genomes and electronic health recor...

Genome Based Taxonomic Classification.

Bacterial populations are routinely characterized based on the microscopic examination, colony formation and biochemical tests. However, in recent past, bacterial identification, classification and no...

The 'Neglected' Personal Neglect.

A review of patients with brain injury showing personal neglect is presented. The aim is to shed light on this aspect of neglect often unresearched or only indirectly investigated, and to discuss rece...

General Data Protection Regulation and medical research: friend or foe?

As of May 2018, the use of personal data in medical research is regulated under the General Data Protection Regulation (GDPR). While, as before, in principle patients' consent for the use of their per...

The refinement of leprosy PCR diagnostics by the amplification of specie-specific repeated fragment of the Mycobacterium leprae genome.

Certain level of new registered cases of leprosy in a number of endemic countries in the world, as well as growing rate of transboundary migratory flows, raise the issue of effective diagnosis of this...

Clinical Trials [1141 Associated Clinical Trials listed on BioPortfolio]

Next Generation pErsonalized tX(Therapy) With mulTi-omics and Preclinical Model]

The next generation of personalized medical treatment according to the type of personal genetic information are evolving rapidly. The genome analysis needs systematic infra and database ba...

Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.

The next generation of personalized medical treatment according to the type of personal genetic information are evolving rapidly. The genome analysis needs systematic infra and database ba...

Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.

The next generation of personalized medical treatment according to the type of personal genetic information are evolving rapidly. The genome analysis needs systematic infra and database ba...

Investigating the Feasibility and Implementation of Whole Genome Sequencing in Patients With Suspected Genetic Disorder

The study "Investigating the Feasibility and Implementation of Whole Genome Sequencing in Patients With Suspected Genetic Disorder" is a research study that aims to explore the use of whol...

Trial Embedded in an Electronic Personal Medical Health Records

This is a research study to determine if a personal health record, called myHERO, will help improve health. A personal health record is a secure internet (also called online) tool that con...

Companies [1880 Associated Companies listed on BioPortfolio]

Personal Genome Diagnostics, Inc.

Personal Genome Diagnostics (PGDx) empowers the fight against cancer by unlocking actionable information from the genome. We are committed to developing a portfolio of regulated t...

Personal Genome Diagnostics Inc.

Personal Genome Diagnostics (PGDx) empowers the fight against cancer by unlocking actionable information from the genome. We are committed to developing a portfolio of regulated t...

Personal Genome Project

The Personal Genome Project is an open-ended research study that aims to improve the understanding of genetic and environmental contributions to human traits. The project is curre...

Longenity Inc

Longenity Inc. is a biotechnology company using genomics, bioinformatics, and systems biology, founded for the purpose of understanding normal aging, and common pathologies of human aging. Longenity ...

GenomeQuest Inc.

GenomeQuest is a global provider of large-scale genomic software applications. Based on a whole/multi-genome hosting platform, the company's products include GQ-IP for global rese...

More Information about "Personal Genome Diagnostics, Inc." on BioPortfolio

We have published hundreds of Personal Genome Diagnostics, Inc. news stories on BioPortfolio along with dozens of Personal Genome Diagnostics, Inc. Clinical Trials and PubMed Articles about Personal Genome Diagnostics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Personal Genome Diagnostics, Inc. Companies in our database. You can also find out about relevant Personal Genome Diagnostics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record